NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Morrisville-based Liquidia Technologies has reported positive initial results from a phase 1 clinical trial of a drug candidate for relieving post-surgery pain as an alternative to addictive opioids.

The North Carolina Biotechnology Center is pleased to welcome our newest Landing Pad tenant, Fluidigm.

A medical device developed by Cook Medical’s endoscopy business unit in Winston-Salem is now being used to help newborns avoid surgery to repair a rare birth defect of the esophagus.

Cambrex Corp., a contract manufacturer of small molecules and active pharmaceutical ingredients (APIs) for drug companies, will invest $2.4 million in an expansion of its pilot plant in High Point to meet growing business demand.

G1 Therapeutics, a clinical-stage oncology company based in Research Triangle Park, became a publicly traded entity today with a $105 million initial public offering of seven million shares of stock priced at $15 a share.

Wilmington-based Pharmaceutical Product Development (PPD), a global contract research organization, has created a new unit combining its medical affairs research operations team with Evidera, a company it acquired in 2016.

Durham-based Patheon N.V., a global provider of pharmaceutical development and manufacturing services that has a large production facility in Greenville, will be acquired by Thermo Fisher Scientific in a deal worth about $5.2 billion.

Two Kansas startup companies won the top prizes at NCBiotech's two-day 2017 Ag Biotech Entrepreneurial Showcase in Durham.

Angel investor networks from the Triangle’s major research universities will make their first joint investment in a medical products firm this week.

A California surgeon has performed the first U.S. bone graft using a pliable foam produced by Research Triangle Park–based medical biomaterials company CURASAN Inc.

A dozen ag biotech startups pitched their wares this week to a receptive crowd at the North Carolina Biotechnology Center’s 2017 Ag Biotech Entrepreneurial Showcase at the Cotton Room in Durham.

Ticket sales close Wednesday, May 10, for a May 17 event featuring a talk by the immediate past U.S. FDA commissioner, Robert Califf, M.D., MACC.

North Carolina won Site Selection Magazine’s Prosperity Cup for 2017, topping all states’ rankings in its May issue.

Glenmark Pharmaceuticals, an India-based global pharmaceutical company, is hiring at its pharmaceutical manufacturing facility in the Union County community of Monroe, outside Charlotte.

Durham-based Parion Sciences has granted exclusive worldwide development and commercialization rights to its potential therapy for dry eye disease to Shire, a global pharmaceutical company.